Neural Cell Adhesion Molecule 1 (NCAM1) (C-Term) Peptid
Kurzübersicht für Neural Cell Adhesion Molecule 1 (NCAM1) (C-Term) Peptid (ABIN8106289)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- NCAM1 Peptide - C-terminal region
-
Sequenz
- AFFAKSAAIY NPVIYIMMNK QFRNCMLTTI CCGKNPLGDD EASATVSKTE
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-NCAM1 Antibody (ARP59939_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CD56 (NCAM1) (Neural Cell Adhesion Molecule 1 (NCAM1))
-
Hintergrund
-
Background Information: Retinitis pigmentosa is an inherited progressive disease which is a major cause of blindness in western communities. It can be inherited as an autosomal dominant, autosomal recessive, or X-linked recessive disorder. In the autosomal dominant form,which comprises about 25 % of total cases, approximately 30 % of families have mutations in the gene encoding the rod photoreceptor-specific protein rhodopsin. This is the transmembrane protein which, when photoexcited, initiates the visual transduction cascade. Defects in this gene are also one of the causes of congenital stationary night blindness.
Alternative Symbols: CD56, MSK39, NCAM
-
Molekulargewicht
- 39kDa
-
Gen-ID
- 4684
-
NCBI Accession
- NP_851996
-
UniProt
- P13591
Target
-